Combination of mifepristone and misoprostol for termination of 8-16 weeks' pregancy: a multicenter, randomized controlled study.

Trial Profile

Combination of mifepristone and misoprostol for termination of 8-16 weeks' pregancy: a multicenter, randomized controlled study.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol (Primary) ; Misoprostol (Primary)
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Company (Shanghai Hualian Pharmaceutical) added as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Actual end date changed from May 2011 to Jun 2011 as reported by Chinese Clinical Trial Register record.
    • 15 Nov 2011 Actual initiation date (1 Jul 2009) added as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top